# Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

> **NCT00589979** · PHASE2 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 169 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Lidoderm (Lidocaine 5% Patch)
- **DRUG:** Placebo Patch

## Key facts

- **NCT ID:** NCT00589979
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-10
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00589979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00589979, "Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00589979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*